Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:RTGN)

3.200 UNCHANGED
Last Price Updated: 10:51 AM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about RTGN

News headline image
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
Zwerling expected to guide the Company to its commercial launch 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
Company to use facility to further development of RetinalGenix’s therapies for neurodegenerative and retinal diseases 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
Company will discuss its patented remote monitoring high-resolution retinal imaging system RetinalCam™ and associated biomarker technologies 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
Appointment Underscores RetinalGenix’s Commitment to Integrating the Latest Advances in Genomics and Personalized Medicine into its Product Pipeline 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
High-Resolution Retinal Imaging Now Using Both Near Infrared And Green Modes 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
A New Patent Granted for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration and Alzheimer’s Syndrome 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
Study Intends To Identify Hematology Biomarkers That May Help Personalize Medical Evaluations For Patients Undergoing Treatments For Wet Macular Degeneration 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
Video Presentation Highlights Combining Genetic Markers with High-Resolution Retinal Imaging to Aid in Detection and Treatment of Blindness and Multiple Systemic Diseases 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
Technology Enables Physicians to Remotely Make Pre-Diagnostic Assessment Regarding Whether an In-Person Diagnostic Examination of Ocular Anatomy is Warranted 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
Study Intends To Identify Hematology Biomarkers That May Help Personalize Medical Evaluations For Patients Undergoing Treatments For Macular Degeneration 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
Watson Hired to Accelerate DNA-Based "GPS" Genetic Testing App Which Combines with RTGN's High-Resolution Retinal Imaging Technologies Seeking to Revolutionize Diagnosis of Systemic Diseases 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
RetinalGeniX Technologies Invites Individual and Institutional Investors, Advisors, and Analysts, to Attend its Real-Time, Interactive Presentation at The Emerging Growth Conference 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
News headline image
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
Appointment Expected to Support Initiatives to Improve Population Health Management and the Company’s Planned Listing Upgrade from OTCBQB to NASDAQ 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.